The bone densitometers market is projected to reach USD 311 million by 2024 from USD 247 million in 2019, at a CAGR of 4.7%. The growth in the bone densitometers market is majorly driven by the increasing prevalence of osteoporosis and the rising geriatric population.
GE Healthcare (US), Hologic, Inc. (US), OSI Systems, Inc. (US), Diagnostic Medical Systems Group (France), Swissray Global Healthcare Holding, Ltd. (Taiwan), BeamMed, Ltd. (Israel), Echolight S.p.A (Italy), Scanflex Healthcare AB (Sweden), Medonica Co., Ltd. (South Korea), and Eurotec Systems S.r.l (Italy) are some of the prominent players operating in this market. These companies are focusing on increasing their presence in the high-growth markets through both organic as well as inorganic growth strategies, such as partnerships.
To know about the assumptions considered for the study download the pdf brochure
GE Healthcare (US) is a prominent player in the bone densitometers market and has a strong presence across the globe. The company provides bone densitometers to various clinical research centers. The company’s significant global footprint can be attributed to its strong sales and distribution network. The company’s Lunar Aria combines advanced technology with an understanding of the challenges of offering cost-effective bone care. It is, therefore, the ideal osteoporosis diagnostic system for private practice and smaller hospitals.
Hologic, Inc. (US) is another key player operating in the bone densitometers market. The company has a well-established product portfolio in the bone densitometers market. The company’s women’s healthcare business units are focused on bone densitometry and mammography. The bone densitometers offered by the company are used in several clinics and hospitals. The company also offers its bone densitometers to pharmaceutical companies, which are used in measuring bone density in patients during clinical trials.
Related Reports:
Bone Densitometer Market by Type (DEXA, Peripheral [Radiography, Quantitative Absorptiometer]), Application (Osteopenia & Osteoporosis, Cystic Fibrosis, CKD, Rheumatoid Arthritis), End User (Hospital, Diagnostic Centres) - Global Forecast to 2024
Contact:
Mr. Shelly Singh
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
[email protected]